Reproductive · Obstetrics
The facts most likely to be tested
Rh(D) alloimmunization occurs when an Rh-negative mother is exposed to Rh-positive fetal blood, leading to the production of anti-D IgG antibodies.
The indirect Coombs test is the initial screening tool used to detect the presence of maternal anti-D antibodies in the serum.
Anti-D immune globulin (RhoGAM) must be administered to all Rh-negative, unsensitized pregnant patients at 28 weeks gestation and within 72 hours of delivery.
RhoGAM is also indicated following any fetomaternal hemorrhage event, including spontaneous abortion, ectopic pregnancy, amniocentesis, or abdominal trauma.
Fetal anemia resulting from hemolytic disease of the fetus and newborn (HDFN) is monitored non-invasively using middle cerebral artery (MCA) peak systolic velocity via Doppler ultrasound.
Hydrops fetalis is the most severe manifestation of alloimmunization, characterized by fetal ascites, pericardial effusion, and skin edema due to high-output heart failure.
Intrauterine fetal blood transfusion is the definitive management for severe fetal anemia detected before the fetus reaches a viable gestational age.
Vignette unlocked
A 28-year-old G2P1 woman at 29 weeks gestation presents for a routine prenatal visit. Her blood type is O negative and her antibody screen at 12 weeks was negative. She did not receive any prenatal care during her first pregnancy. Current laboratory testing reveals a positive indirect Coombs test with a titer of 1:32. Ultrasound shows fetal ascites and pericardial effusion.
What is the most appropriate next step in the management of this fetus?
Middle cerebral artery (MCA) peak systolic velocity Doppler ultrasound
The patient is already sensitized (positive indirect Coombs), making RhoGAM ineffective; the next step is to assess for fetal anemia using MCA Doppler to determine if intrauterine transfusion is required.
Full handout
High yield triage
Etiology / Epidemiology
Occurs when Rh-negative mother carries Rh-positive fetus; maternal antibodies form after initial exposure.
Clinical Manifestations
Often asymptomatic in mother; fetus presents with hydrops fetalis, severe anemia, and jaundice.
Diagnosis
Indirect Coombs test screens mother; Amniotic fluid spectrophotometry (delta OD450) assesses fetal hemolysis.
Treatment
Rho(D) immune globulin at 28 weeks and within 72 hours of delivery; do not administer if already sensitized.
Prognosis
Untreated leads to erythroblastosis fetalis; high risk of kernicterus and fetal demise.
Full handout
Epidemiology & Etiology
Affects Rh-negative women exposed to fetal blood via fetomaternal hemorrhage. Risk factors include spontaneous abortion, ectopic pregnancy, and invasive procedures like amniocentesis. Sensitization typically occurs during the first pregnancy or delivery.
Pertinent Anatomy
The placenta acts as the interface where fetal red blood cells enter maternal circulation. The fetal liver and spleen become sites of extramedullary hematopoiesis in response to severe anemia.
Pathophysiology
Maternal IgG antibodies cross the placenta and destroy fetal RBCs, leading to hemolytic anemia. The fetus compensates with massive production of immature RBCs, known as erythroblastosis fetalis. Severe hemolysis results in hydrops fetalis, characterized by ascites, pericardial effusion, and skin edema.
Clinical Manifestations
Mothers are typically asymptomatic. Fetal signs include tachycardia on non-stress tests and hydrops fetalis on ultrasound. Neonates may present with severe jaundice, hepatosplenomegaly, and kernicterus (bilirubin-induced brain damage).
Diagnosis
Screening via Indirect Coombs test identifies maternal antibodies. If positive, monitor fetal status using Middle Cerebral Artery (MCA) Doppler to detect peak systolic velocity indicating anemia. Amniocentesis for bilirubin levels (delta OD450) is the definitive assessment for severity.
Treatment
Administer Rho(D) immune globulin (RhoGAM) at 28 weeks gestation and within 72 hours of delivery. Contraindicated in patients already sensitized (positive antibody screen). Severe cases require intrauterine fetal blood transfusion.
Prognosis
Without intervention, hydrops fetalis carries a high mortality rate. Survivors are at risk for sensorineural hearing loss and developmental delay due to hyperbilirubinemia.
Differential Diagnosis
ABO incompatibility: usually milder, occurs in first pregnancy
Parvovirus B19: causes fetal anemia and hydrops without maternal alloimmunization
Fetal-maternal hemorrhage: acute drop in fetal hemoglobin without maternal antibodies
Twin-twin transfusion syndrome: discordant fetal weights and amniotic fluid volumes
Congenital infections: TORCH infections causing hepatosplenomegaly